Pharmacist supply

The new Bureau of Health Professions (BHPr) pharmacist supply model... 

Figure 25.1 Active pharmacists in the U.S. 1980-2010. (Source BHPr Pharmacist Supply Model.)...

Figure 25.12 Relative growth rates. (Sources IMS Health [prescription and dollar value] BHPr Pharmacist Supply Model [pharmacists].)...

Gershon SK, Cultice JM, Knapp KK. Further research on pharmacist supply trends revised projections through 2020. Presented at the American Pharmaceutical Association Annual Meeting, San Francisco, CA, March 2001. 

Mott, D.A. Kreling, D.H. An internal rate of return approach to investigate pharmacist supply in the United States. Health Econ. 1994, 3 (6), 373-384. 

While the principal value of the book is for the professional chemist or student of chemistry, it should also be of value to many people not especially educated as chemists. Workers in the natural sciences—physicists, mineralogists, biologists, pharmacists, engineers, patent attorneys, and librarians—are often called upon to solve problems dealing with the properties of chemical products or materials of construction. Eor such needs this compilation supplies helpful information and will serve not only as an economical substitute for the costly accumulation of a large library of monographs on specialized subjects, but also as a means of conserving the time required to search for... 

A separately packaged sterile diluent and sterile dropper assembly is provided with the sterile powder and requires aseptic technique to reconstitute. The pharmacist should only use the diluent supplied by the manufacturer since it has been developed to maintain the optimum potency and preservation of the reconstituted solution. The storage conditions and expiration dating for the final solution should be emphasized to the patient. 

V. CHANGES IN PHARMACIST DEMOGRAPHICS AND SUPPLY VERSUS DEMAND... 

Paragraph 4 sets out an exemption in certain circumstances for medicinal products not requiring a prescription for sale or supply, which are prepared by, or under, the supervision of a pharmacist and are sold or supplied to a person exclusively for use by him in the course of his business for the purpose of administration to one or more persons. 

Rule 13(1) of the Poisons Rules (1972) allowed a pharmacist to supply a POM medicine without a prescription when, by reason of some emergency, a doctor was imable to furnish a prescription immediately. 

Regarding the sale and supply, the natural tendency of medicinal products approved in the United Kingdom was a pharmacy sale under the supervision of a pharmacist, unless restrictions were relaxed or tightened. Legislation had already existed in the United States (Durham-Humphrey Amendment of 1951) that defined the kinds of drugs that could not be safely used without medical supervision and restricted... 

Schedule 3 - non-prescription medicines for supply by pharmacists only... 

The Royal Pharmaceutical Society of Great Britain has issued guidance in relation to the acceptance of gifts and inducements to prescribe or supply. The Society states that pharmacists accepting items such as gift vouchers, bonus points, discount holidays, sports equipment etc would be in breach of the Society s Code of Ethics and advises pharmacists not to participate in such offers. 

Health sector development is a vital government obligation. In a national health system, proper use of well known and newer essential medicines for priority health problems depends on certain minimal level of medical and pharmaceutical services. This includes inexpensive diagnostic test to confirm diagnosis, and well-informed trained clinicians, pharmacists, nurses and other health staff to help patients, especially those with chronic illnesses, to adhere to their treatments. An overall capacity strengthening of the health and supply systems is a pre-requisite to respond adequately to the increased medical and pharmaceutical needs of populations. 

Pharmaceutical distributors, wholesalers, importers, exporters, all those involved in the distribution chain are key players that, maybe more than others, should improve their capacity to combat counterfeit medicines. It is through the distribution chain that counterfeit medicines reach patients. It is therefore essential that distributors, wholesalers, importers, exporters develop and effectively implement business practices that make the distribution chain as impermeable as possible to counterfeits and open to appropriate verification by national authorities. It is known that in many countries unauthorized trade is widespread and that it is difficult to get unauthorized traders to respect rules and regulations. Yet, if unauthorized trade is the result of many factors, local distributors and retail pharmacists may find themselves part of the problem (for having left important areas of the country without effective supply mechanisms)... 

Durham-Humphrey Act(1952) - This amendment defined specific drugs which may be supplied by a licensed pharmacist upon the prescription by a registered physician. Under this act these drug prescriptions may not be refilled unless authorized by the physician. 

---